Director Paul B Manning Files to Sell $11.1M in Liquidia Stock Amidst Broader Insider Distribution
LQDA has more than doubled off its 52-week low of $11.85 on elevated volume (3.1× avg).
Summary
Director Paul B Manning has filed a Form 144 to sell $11.1 million in Liquidia Corp common stock, contributing to a notable trend of insider distribution as the stock trades near its 52-week high.
Key Events · Ownership and Investor Activity · LQDA
-
Director Plans Significant Sale
Paul B Manning, a Director, intends to sell 200,000 shares of common stock valued at approximately $11.1 million.
-
Continuation of Insider Selling Trend
This filing follows a pattern of substantial insider sales, with over $66 million in net sales by 11 active insiders in the past 90 days, including multiple Form 144 filings by directors and affiliated entities.
-
Stock Trading Near 52-Week High
The planned sale occurs while Liquidia's stock is trading close to its 52-week high, suggesting insiders may be locking in gains.
Analysis · LQDA · Life Sciences
Director Paul B Manning's intent to sell $11.1 million worth of common stock adds to a significant pattern of insider selling at Liquidia Corp, which has seen over $66 million in net sales by insiders in the last 90 days. This selling occurs while the stock is trading near its 52-week high, potentially indicating profit-taking by insiders despite recent positive earnings reports. The ongoing patent and trade secret litigation mentioned in the Q1 2026 report could be a factor influencing these sales.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, LQDA was trading at $63.00 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.6B. The 52-week trading range was $11.85 to $66.24. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.